Larson Financial Group »

Aeglea Biotherapeutics shares owned by Larson Financial Group

Quarter-by-quarter ownership of Aeglea Biotherapeutics (SYRE) shares owned by Larson Financial Group from 13F filings

Historical chart of Larson Financial Group investment in Aeglea Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aeglea Biotherapeutics held by Larson Financial Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aeglea Biotherapeutics by Larson Financial Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $4.7k 144 32.76
2025-09-30 $201 12 16.75
2025-06-30 $90 6 15.00
2025-03-31 $710 44 16.14

More positions owned by Larson Financial Group

Spdr Series Trust State Street Spd (SPYM)
Apple (AAPL)
Wisdomtree Tr Us Qtly Div Grt (DGRW)
American Centy Etf Tr Us Quality Grow (QGRO)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Mid Cap Etf (VO)
Capital Group Global Equity SHS (CGGE)
Franklin Templeton Etf Tr Us Mid Cp Mltfct (FLQM)
Invesco Exchange Traded Fd T Rafi Us 1000 Etf (PRF)
Microsoft Corporation (MSFT)
Ishares Tr Msci Intl Qualty (IQLT)
J P Morgan Exchange Traded F Active Bond Etf (JBND)
Applied Materials (AMAT)
Fidelity Merrimack Str Tr Total Bd Etf (FBND)
Pgim Etf Tr Active Aggregate (PAB)

View all positions for Larson Financial Group

Top funds holding Aeglea Biotherapeutics

FMR
Vanguard Group
Fairmount Funds Management
BlackRock
VR Adviser
Rtw Investments
Tang Capital Management
Capital Research and Management Company - Division 3
State Street Corporation
Driehaus Capital Management
Commodore Capital
Geode Capital Management
Wellington Management Company
Braidwell
Paradigm Biocapital Advisors

View all funds holding Aeglea Biotherapeutics